A Nationwide Study of GATA2 Deficiency in Norway—the Majority of Patients Have Undergone Allo-HSCT

PURPOSE: GATA2 deficiency is a rare primary immunodeficiency that has become increasingly recognized due to improved molecular diagnostics and clinical awareness. The only cure for GATA2 deficiency is allogeneic hematopoietic stem cell transplantation (allo-HSCT). The inconsistency of genotype–pheno...

Descripción completa

Detalles Bibliográficos
Autores principales: Jørgensen, Silje F., Buechner, Jochen, Myhre, Anders E., Galteland, Eivind, Spetalen, Signe, Kulseth, Mari Ann, Sorte, Hanne S., Holla, Øystein L., Lundman, Emma, Alme, Charlotte, Heier, Ingvild, Flægstad, Trond, Fløisand, Yngvar, Benneche, Andreas, Fevang, Børre, Aukrust, Pål, Stray-Pedersen, Asbjørg, Gedde-Dahl, Tobias, Nordøy, Ingvild
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664000/
https://www.ncbi.nlm.nih.gov/pubmed/34893945
http://dx.doi.org/10.1007/s10875-021-01189-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664000/
https://www.ncbi.nlm.nih.gov/pubmed/34893945
http://dx.doi.org/10.1007/s10875-021-01189-y

Ejemplares similares